Avai Bio

AVAI · OTC

$0.115+$0.003 (+2.68%)TodayMarket closed ·
Prev close $0.112

About AVAI

The company is headquartered in Las Vegas, Nevada. The company went IPO on 2019-05-02.

Employees
0
Headquarters
Las Vegas, Nevada
Listed
May 2, 2019
Sector
Information Technology
Industry
IT Services

AVAI key statistics

Market cap
17.24M
Price-earnings ratio
—
Dividend yield
—
Average volume
76.14K
Volume
259.62K
Open price
$0.113
High today
$0.1174
Low today
$0.10
52 Week high
$0.80
52 Week low
$0.1012

Avai Bio (AVAI) at a glance

Avai Bio (AVAI) last traded at $0.115, with a market cap of 17.24M.

Today the stock has traded between $0.10 and $0.1174. The current price is 15.0% above the day's low and 2.0% below its high.

Volume so far is 259.62K shares, above the average of 76.14K shares a day.

Over the past year Avai Bio has ranged from $0.1012 to $0.80, and now sits 2% of the way up that range.

AVAI news

  • Press releaseGlobe Newswire

    Replacing Insulin Cells Works. Keeping The Cells Alive Is the Trick

  • Press releasePRNewswire

    A Diabetes Therapy Just Locked In Its Cell Supplier, and the Race to End Insulin Injections Is Heating Up

  • Press releasePRNewswire

    Avaí Bio and Austrianova Reach Agreement for Insulin-Producing Cells with Internationally Acclaimed Partner to Advance Diabetes Therapy

  • Press releasePRNewswire

    The Longevity Protein Race Reaches Manufacturing: One Microcap Just Completed A GMP Master Cell Bank For Its Anti-Aging Klotho Therapy

  • Press releasePRNewswire

    Anti-Aging Cell Therapy Reaches Major GMP Milestone as Wave of Clinical Advancements Gain Momentum

  • Press releasePRNewswire

    Cell-Based Therapies Poised to Disrupt Multi-Billion-Dollar Anti-Aging and Neurodegenerative Markets

  • Press releasePRNewswire

    Avaí Bio and Austrianova Complete GMP Master Cell Bank, Begin Viral Testing for Cell-Based Klotho Anti-Aging Therapy

  • Press releasePRNewswire

    A Unique Klotho-based Anti-Aging Therapy to Be Introduced at a Premier Longevity Forum: Inside Avaí Bio's Cell-Based Platform Approach

Similar companies

Companies in the same industry as Avai Bio

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.